Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2016-000864-41Phase 2Completed
Phase 2, randomised trial of lidocaine in phantom limb pain (PLP), post-amputation pain (PAP) and scar hyperalgesia (2 arms), sponsored by CHU Brugmann. Primary endpoint: Reported overall daily pain intensity. Started Mar 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2016-000864-41.